SCM
ZYME icon

Soleus Capital Management’s Zymeworks ZYME Stock Holding History

Soleus Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-327,900
Closed -$11.8M – 75
2020
Q2 		$11.8M Buy
+327,900
New +$12.1M 6.74% 3

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Soleus Capital Management's ZYME Position: Q2 2026 in Review

Soleus Capital Management sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 10,000 shares — an estimated $250K sold.

Soleus Capital Management first reported a position in ZYME in Q4 2019 and held it in 7 quarters. The position peaked at $15.2M in Q2 2020. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Soleus Capital Management reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
  • Soleus Capital Management sold 10,000 Zymeworks shares in Q2 2026, an estimated $250K.
  • Soleus Capital Management first reported a position in Zymeworks in Q4 2019 and held it in 7 quarters.
  • Soleus Capital Management's Zymeworks position peaked at $15.2M in Q2 2020.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.